News tagged with drug trials

New statistics methods for dose finding studies

Less than 0.02 per cent of potential active ingredients pass clinical tests and become commercially viable. However, it is possible that some candidates are rejected without good reason, suspects mathematician Prof Dr Holger ...

dateApr 21, 2015 in Mathematics
shares40 comments 0

Pfizer anti-smoking drug has heart risks: US

US regulators said Thursday that the label on Pfizer's anti-smoking drug Chantix must be changed to warn of a slightly higher risk of heart problems in patients who already have cardiovascular disease.

dateJun 16, 2011 in Medications
shares0 comments 0

Pfizer says patient died in oral RA drug study

(AP) -- Pfizer Inc. confirmed that one patient who was taking its drug candidate tofacitinib, a pill designed to treat rheumatoid arthritis, died during a recent clinical trial and said the death was connected to the drug.

dateApr 22, 2011 in Medications
shares0 comments 0